Information  X 
Enter a valid email address

Oilex Ltd (OEX)

  Print          Annual reports

Tuesday 04 January, 2022

Oilex Ltd

Placement - Issue of Securities

RNS Number : 2542X
Oilex Ltd
04 January 2022


ASX - RNS Announcement


4 January 2022











Further to Oilex Ltd's (Oilex or the Company) announcement on 14 December 2021, confirming that it had arranged the funding required for the re-fraccing of the Cambay 77H well in India via an equity capital raising of £2.0 million (A$3.7 million), before costs, the Company is pleased to announce it has settled a further £0.31 million (A$0.57 million) before costs, via the issue of 222,005,826 fully paid ordinary shares (Shares), bringing the total settlement proceeds to £0.8 million.


The remaining Placement funds of approximately £1.2 million are anticipated for settlement by 12 January 2022.  


Of the current tranche of 222,005,826 Shares issued, the Company has issued:

· 219,523,143 Placement Shares under the Company's current ASX Listing Rule 7.1A placement capacity; and.

· 2,482,683 Placement Shares under the Company's current ASX Listing Rule 7.1 placement capacity.

(the remaining LR7.1 Placement Shares to be completed with the last settlement, in early January 2022).



AIM Admission and Total Voting Rights 


Application has been made to the London Stock Exchange plc for the admission of 222,005,826 Shares   to trade on AIM ( Admission ). Admission of the Shares is expected to become effective and dealings to commence at 8.00 a.m. on 10 January 2022.  Following Admission, the Company will have 6,261,880,020 shares in issue. The Company does not currently hold any shares in treasury.  Accordingly, the total number of voting rights will be 6,261,880,020.




Section 708A(5)(e) Statement


The Corporations Act (Cth) (Act) restricts the on-sale of securities issued without disclosure, unless the sale is exempt under section 708 or 708A of the Act. By giving this notice, the on sale of the Shares noted above will fall within the exemption in section 708A(5) of the Act.


Pursuant to the issue of the 222,005,826 Ordinary Shares on 24 December 2021, Oilex gives notice under section 708A(5)(e) of the Act that:


1)  Oilex issued the Shares without disclosure to investors under Part 6D.2 of the Act;


2)  As at the date of this notice, Oilex has complied with:

a)  the provisions of Chapter 2M of the Act as they apply to Oilex; and

b)  section 674 of the Act; and


3)  As at the date of this notice, there is no information:

(i)  That has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

(ii)  That investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

A. The assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

B. The rights and liabilities attaching to the Shares.


The relevant Appendix 2A was lodged via ASX on-line forms


For and on behalf of Oilex Ltd



Suzie Foreman

Company Secretary






For further information, please contact:


Investor Enquires

Oilex Ltd

Roland Wessel

Chief Executive Officer

Email: [email protected]

Tel: +61 8 9485 3200


AIM Broker

Novum Securities


Colin Rowbury

Email: [email protected]

Tel: +44 20 7399 9427


AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer 

Email: [email protected]

Tel: +44 20 7409 3494


Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: [email protected]

[email protected]

Tel:+ 44 20 7390 0230




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t